Two Sigma Investments LP grew its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 24.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 700,500 shares of the company's stock after buying an additional 136,624 shares during the period. Two Sigma Investments LP owned 1.41% of Nu Skin Enterprises worth $4,826,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently modified their holdings of NUS. Rhumbline Advisers raised its stake in Nu Skin Enterprises by 70.9% during the fourth quarter. Rhumbline Advisers now owns 138,477 shares of the company's stock valued at $954,000 after purchasing an additional 57,443 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Nu Skin Enterprises by 18.5% in the fourth quarter. Bank of New York Mellon Corp now owns 613,330 shares of the company's stock worth $4,226,000 after purchasing an additional 95,938 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in shares of Nu Skin Enterprises during the fourth quarter worth approximately $115,000. US Bancorp DE raised its stake in shares of Nu Skin Enterprises by 424.2% during the fourth quarter. US Bancorp DE now owns 7,460 shares of the company's stock valued at $51,000 after acquiring an additional 6,037 shares in the last quarter. Finally, SBI Securities Co. Ltd. purchased a new stake in shares of Nu Skin Enterprises in the fourth quarter valued at approximately $157,000. Institutional investors own 82.84% of the company's stock.
Nu Skin Enterprises Stock Performance
Shares of NYSE NUS traded up $0.23 during midday trading on Friday, reaching $8.63. The company had a trading volume of 1,174,942 shares, compared to its average volume of 837,059. Nu Skin Enterprises, Inc. has a 1 year low of $5.32 and a 1 year high of $13.90. The business's 50-day simple moving average is $6.62 and its 200 day simple moving average is $7.05. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56. The stock has a market cap of $426.43 million, a P/E ratio of -2.93 and a beta of 0.92.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.15 by $0.08. The company had revenue of $364.49 million during the quarter, compared to the consensus estimate of $352.06 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. On average, analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Shareholders of record on Friday, May 30th will be given a $0.06 dividend. The ex-dividend date is Friday, May 30th. This represents a $0.24 annualized dividend and a yield of 2.78%. Nu Skin Enterprises's dividend payout ratio is presently -30.00%.
Insider Transactions at Nu Skin Enterprises
In other Nu Skin Enterprises news, insider Steven Keith Hatchett purchased 6,500 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The stock was purchased at an average price of $7.54 per share, for a total transaction of $49,010.00. Following the purchase, the insider now directly owns 162,065 shares in the company, valued at approximately $1,221,970.10. This trade represents a 4.18% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.00% of the company's stock.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded Nu Skin Enterprises from a "hold" rating to a "buy" rating in a report on Monday, May 12th.
Get Our Latest Research Report on NUS
About Nu Skin Enterprises
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Read More
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
